ProfileGDS4132 / 228899_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 33% 26% 42% 41% 34% 30% 38% 38% 41% 35% 41% 31% 40% 40% 44% 39% 43% 41% 37% 35% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10183.877233
GSM201543Muscle PCOS pioglitazone 12154.746726
GSM201544Muscle PCOS pioglitazone 161111.42342
GSM201545Muscle PCOS pioglitazone 201115.06541
GSM201829Muscle PCOS pioglitazone 23190.617434
GSM201830Muscle PCOS pioglitazon 25176.239330
GSM201831Muscle PCOS pioglitazone 27195.621338
GSM201832Muscle PCOS pioglitazone 3196.301238
GSM201833Muscle PCOS pioglitazone 41100.04241
GSM201834Muscle PCOS pioglitazone 8186.128835
GSM201835Muscle PCOS after pioglitazone 10293.08941
GSM201836Muscle PCOS after pioglitazone 12265.753231
GSM201837Muscle PCOS after pioglitazone 16288.808840
GSM201838Muscle PCOS after pioglitazone 20293.716440
GSM201839Muscle PCOS after pioglitazone 232108.64344
GSM201840Muscle PCOS after pioglitazone 25296.784839
GSM201841Muscle PCOS after pioglitazone 27297.959243
GSM201842Muscle PCOS after pioglitazone 3286.794341
GSM201843Muscle PCOS after pioglitazone 4292.809537
GSM201844Muscle PCOS after pioglitazone 8282.706735